Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells
about
Mesenchymal stem cells avoid allogeneic rejectionThe zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signalingSalt restriction leads to activation of adult renal mesenchymal stromal cell-like cells via prostaglandin E2 and E-prostanoid receptor 4Prostanoid receptor antagonists: development strategies and therapeutic applicationsMicroarray Analysis of Gene Expression Reveals that Cyclo-oxygenase-2 Gene Therapy Up-regulates Hematopoiesis and Down-regulates Inflammation During Endochondral Bone Fracture Healing.RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravityHormone-sensitive lipase-knockout mice maintain high bone density during aging.Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2.Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allograftsReduced COX-2 expression in aged mice is associated with impaired fracture healing.Synergistic induction of early stage of bone formation by combination of recombinant human bone morphogenetic protein-2 and epidermal growth factor.Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo.Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems.Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null miceMesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.Regulation of chondrogenesis and chondrocyte differentiation by stress.COX2 inhibition reduces aortic valve calcification in vivoProstaglandin E2 (PGE2) exerts biphasic effects on human tendon stem cells.NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man.Mechanisms of gravitational sensitivity of osteogenic precursor cells.Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system.BMP-2 mediates PGE(2) -induced reduction of proliferation and osteogenic differentiation of human tendon stem cells.Implications of mesenchymal stem cells in regenerative medicine.Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.Noncanonical BMP signaling regulates cyclooxygenase-2 transcription.Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism.Cationic Nanogel-mediated Runx2 and Osterix siRNA Delivery Decreases Mineralization in MC3T3 Cells.BMP-2 induces ATF4 phosphorylation in chondrocytes through a COX-2/PGE2 dependent signaling pathway.Influence of non-steroidal anti-inflammatory drugs (NSAIDs) on osseointegration of dental implants in rabbit calvaria.FGF-2 enhances Runx-2/Smads nuclear localization in BMP-2 canonical signaling in osteoblasts.Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.Hypoxia and Reactive Oxygen Species Homeostasis in Mesenchymal Progenitor Cells Define a Molecular Mechanism for Fracture Nonunion.Cyclooxygenase-2 inhibition selectively attenuates bone morphogenetic protein-6 synthesis and bone formation during guided tissue regeneration in a rat model.MicroRNA‑218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15‑hydroxyprostaglandin dehydrogenase [NAD(+)].Indomethacin induces differential effects on in vitro endochondral ossification depending on the chondrocyte's differentiation stage.Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats.Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.Enamel matrix derivative exhibits anti-inflammatory properties in monocytes.Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis.
P2860
Q21245658-1AD0F606-7022-43EA-A5CD-B2255706C36EQ28593888-1A21C2FD-021C-4D42-944A-3A59A23258CFQ30359331-B1667A24-4896-4E26-8614-8F42C4F06909Q33485483-FC10115B-7713-480C-9EF9-2B1EFDC8A9C7Q34219169-BBD6A358-BB0B-4E9D-9218-D2BD31946FD0Q34312867-49A48B93-D03C-4865-A93E-695D7C78D8B4Q35105396-6ED981D4-2F20-443B-AF2C-BF71EB916654Q35156052-93098C88-41D0-4D33-A828-A483BECDC3A8Q35683015-BB6ECE98-4D72-41F1-9B8E-02E366270548Q35748166-9602DC72-9E66-4CC9-BA14-97D308FA291DQ35835009-5C938F1B-E273-4290-88EE-AA6C0FAD98B4Q35865353-5C7EBD1F-6EFC-4C16-BD44-AEF7AF715367Q36054538-F5BE0ED9-8C3F-4DBA-9876-3B378D75EA4DQ36287687-661C4582-8C92-48C5-B490-27AD1F167BC4Q36512269-1B3BC8B1-C350-4F2C-A4FE-6F86B15ECA14Q36734065-DF1E2068-F0B0-496B-B5F6-47D61BEDD8D9Q37075891-91725E0E-EAE6-443B-86E8-A38F41AC8764Q37164445-2DA5F952-04DC-4E3D-8619-910F436ED69CQ37554357-C2EE075D-B633-4BAC-84C7-D1B43CF34649Q37580226-B1CFFAFE-1B14-4605-BDA0-64878887A55DQ38014842-9210F856-088F-4FA3-93C5-5903F58A1D06Q38262146-840206AD-88E1-4C27-AAB5-9CF8D8ECAB31Q38656642-6CA92B46-DA57-4230-8644-E3C50BD14CD0Q38693545-ED07A951-C22C-478C-AF4A-54A2411AD09CQ39266751-490E4736-6348-4E3B-9501-5197403C0989Q39570977-87F0626A-9421-4D63-8053-B96A84A3E108Q39673628-F1E4FA2F-4E65-46A7-BDFE-E097233FF7C6Q40241762-37D1BF52-E519-4F7C-9A99-14E5D8A1E5CCQ41807178-ADB91546-9574-45CA-BF8A-E76899C76258Q43438131-D485ADC0-02B9-426C-A2F2-6DCF842950C8Q44034724-F3314F1F-AFA9-4E7A-848E-E40140CD3504Q44624124-446B219A-90E3-4AB6-B2CC-402C3BC347E4Q46539217-BAF13F68-CE9D-4000-A915-D49D23B5FDB2Q46915323-8CDB7B0F-9929-4A7D-9BCB-B6B5CC6AD3EAQ47437884-B4981599-8AD4-47A0-82CB-C05D1B97C32DQ50201286-9C30FE78-6BD4-4507-8477-CDDBF6201E87Q51121350-1E6CD0E0-3882-4038-85C5-5367891FD3B6Q51758610-2AD600B2-40EC-47AA-AEB7-D718CAB67DD8Q53494908-6866850A-4CD1-4749-88CC-E8904D39C63CQ55055573-48733009-F21F-4BE1-B0E5-0F7FE7FC8096
P2860
Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@ast
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@en
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@nl
type
label
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@ast
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@en
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@nl
prefLabel
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@ast
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@en
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@nl
P2093
P356
P1476
Regulation of bone morphogenet ...... n human mesenchymal stem cells
@en
P2093
Ikuo Morita
Toshitaka Arikawa
P356
10.1002/JCP.20031
P407
P577
2004-09-01T00:00:00Z